Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Stine Dam Henriksen"'
Autor:
Benjamin Emil Stubbe, Anders Christian Larsen, Poul Henning Madsen, Henrik Bygum Krarup, Inge Søkilde Pedersen, Søren Lundbye-Christensen, Carsten Palnæs Hansen, Jane Preuss Hasselby, Astrid Zedlitz Johansen, Ole Thorlacius-Ussing, Julia Sidenius Johansen, Stine Dam Henriksen
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCurrent prognostic blood-based biomarkers for pancreatic adenocarcinoma (PDAC) are limited. Recently, promoter hypermethylation of SFRP1 (phSFRP1) has been linked to poor prognosis in patients with gemcitabine-treated stage IV PDAC. This
Externí odkaz:
https://doaj.org/article/f44347b6f1ea445e969725de09fab180
Publikováno v:
Epigenomes, Vol 5, Iss 2, p 8 (2021)
Pancreatic adenocarcinoma has a horrible prognosis, which is partly due to difficulties in diagnosing the disease in an early stage. Additional blood-born biomarkers for pancreatic adenocarcinoma are needed. Epigenetic modifications, as changes in DN
Externí odkaz:
https://doaj.org/article/ef9eb268b8cd4439873f12a26c1fd21a
Autor:
Martin Nygård Johansen, Ole Thorlacius-Ussing, Anders Christian Larsen, Benjamin Emil Stubbe, Henrik Krarup, Stine Dam Henriksen, Poul Henning Madsen, Inge Søkilde Pedersen
Publikováno v:
Stubbe, B E, Henriksen, S D, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, M N & Thorlacius-Ussing, O 2021, ' Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma ', Cancers, vol. 13, no. 22, 5717 . https://doi.org/10.3390/cancers13225717
Cancers, Vol 13, Iss 5717, p 5717 (2021)
Cancers
Cancers; Volume 13; Issue 22; Pages: 5717
Cancers, Vol 13, Iss 5717, p 5717 (2021)
Cancers
Cancers; Volume 13; Issue 22; Pages: 5717
Simple Summary Pancreatic adenocarcinoma (PDAC) is a disease with an incredibly grim prognosis. Most patients die within one year of receiving the diagnosis. There are currently very few tools to help the clinician decide between treatment options an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc9378191dcc9f3ceed6e6622a47f892
https://vbn.aau.dk/da/publications/c57e2f02-b218-4ee6-aacb-a6e60fc19a9d
https://vbn.aau.dk/da/publications/c57e2f02-b218-4ee6-aacb-a6e60fc19a9d
Autor:
Benjamin Emil Stubbe, Inge Søkilde Pedersen, Ole Thorlacius-Ussing, Poul Henning Madsen, Carsten Palnæs Hansen, Stine Dam Henriksen, Martin Nygård Johansen, Julia S. Johansen, Benny V. Jensen, Henrik Krarup
Publikováno v:
Henriksen, S D, Stubbe, B E, Madsen, P H, Johansen, J S, Jensen, B V, Hansen, C P, Johansen, M N, Pedersen, I S, Krarup, H & Thorlacius-Ussing, O 2021, ' Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma – An external validation study ', Pancreatology, vol. 21, no. 6, pp. 1081-1091 . https://doi.org/10.1016/j.pan.2021.05.003
Background We recently identified a diagnostic prediction model based on promoter hypermethylation of eight selected genes in plasma cell-free (cf) DNA, which showed promising results as a diagnostic biomarker for pancreatic ductal adenocarcinoma (PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616e6d1c3442ffbc17067621f06b44db
https://vbn.aau.dk/ws/files/454169083/1_s2.0_S142439032100154X_main.pdf
https://vbn.aau.dk/ws/files/454169083/1_s2.0_S142439032100154X_main.pdf
Autor:
Benjamin Emil Stubbe, Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Henrik Krarup, Inge Søkilde Pedersen, Martin Nygaard Johansen, Ole Thorlacius-Ussing
Publikováno v:
Stubbe, B, Henriksen, S D, Madsen, P H, Larsen, A C, Krarup, H B, Pedersen, I S, Johansen, M N & Thorlacius-Ussing, O 2021, ' SFRP1 Promoter Hypermethylation as a Predictor of Survival and Gemcitabine Efficiency in Patients with Stage IV Pancreatic Adenocarcinoma ', Danske Kræftforskningsdage 2021, Odense, Denmark, 26/08/2021-27/08/2021 .
Aalborg University
Aalborg University
Introduction: No reliable predictive blood-based biomarkers are available for determining survival from pancreatic cancer. This combined explorative and validation study examines promoter hypermethylation of Secreted frizzled-related protein 1 (phSFR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::37f9ef9656ef69e9301314bc40658b7e
https://vbn.aau.dk/ws/files/468225790/SFRP1_promoter_hypermethylation_as_a_prognostic_marker.pdf
https://vbn.aau.dk/ws/files/468225790/SFRP1_promoter_hypermethylation_as_a_prognostic_marker.pdf
Autor:
Peter Brøndum Mortensen, Stine Dam Henriksen, Mogens Tornby Stender, Ole Thorlacius-Ussing, Kasper Lenni Andersen, Rasmus Virenfeldt Flak, Mogens Sall, Thomas Mandøe Jensen
Publikováno v:
Flak, R V, Stender, M T, Jensen, T M, Andersen, K L, Henriksen, S D, Mortensen, P B, Sall, M & Thorlacius-Ussing, O 2019, ' Treatment of locally advanced pancreatic cancer with irreversible electroporation – a Danish single center study of safety and feasibility ', Scandinavian Journal of Gastroenterology, vol. 54, no. 2, pp. 252-258 . https://doi.org/10.1080/00365521.2019.1575465
Objectives: Irreversible electroporation (IRE) is a novel non-thermal ablative technique applied in the treatment of unresectable locally advanced pancreatic cancer (LAPC). This paper reports on the initial experience with IRE of unresectable LAPC in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afabf77a949c6cb43618dcb0216a64a
https://doi.org/10.1080/00365521.2019.1575465
https://doi.org/10.1080/00365521.2019.1575465
Autor:
Stine Dam Henriksen, Inge Søkilde Pedersen, Poul Henning Madsen, Martin Berg Johansen, Anders Christian Larsen, Henrik Krarup, Ole Thorlacius-Ussing
Publikováno v:
International Journal of Cancer. 141:2489-2497
Correct staging of pancreatic cancer is paramount, as treatment is stage specific. However, minimally invasive tools to facilitate staging are lacking. DNA promoter hypermethylation is a hallmark of cancer. The aim of this study is to evaluate promot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f52d186e372e64ccfcc104eaf1d3a938
https://doi.org/10.1002/ijc.31024
https://doi.org/10.1002/ijc.31024
Autor:
Anders Christian Larsen, Ole Thorlacius-Ussing, Poul Henning Madsen, Henrik Krarup, Martin Berg Johansen, Inge Søkilde Pedersen, Stine Dam Henriksen
Publikováno v:
Oncotarget
Henriksen, S D, Madsen, P H, Larsen, A C, Berg Johansen, M, Pedersen, I S, Krarup, H & Thorlacius-Ussing, O 2017, ' Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma ', OncoTarget, vol. 8, no. 55, pp. 93942-93956 . https://doi.org/10.18632/oncotarget.21397
Henriksen, S D, Madsen, P H, Larsen, A C, Berg Johansen, M, Pedersen, I S, Krarup, H & Thorlacius-Ussing, O 2017, ' Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma ', OncoTarget, vol. 8, no. 55, pp. 93942-93956 . https://doi.org/10.18632/oncotarget.21397
// Stine Dam Henriksen 1, 2, 3, 4 , Poul Henning Madsen 5 , Anders Christian Larsen 1 , Martin Berg Johansen 6 , Inge Sokilde Pedersen 5 , Henrik Krarup 4, 5 and Ole Thorlacius-Ussing 1, 3, 4 1 Department of Gastrointestinal Surgery, Aalborg Universi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a721278e76404a423e38741c35d6359c
http://europepmc.org/articles/PMC5706846
http://europepmc.org/articles/PMC5706846
Autor:
Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Martin Nygaard Johansen, Asbjørn Drewes, Inge Søkilde Pedersen, Henrik Krarup, Ole Thorlacius-Ussing
Publikováno v:
Henriksen, S D, Madsen, P H, Larsen, A C, Berg Johansen, M, Drewes, A, Pedersen, I S, Krarup, H & Thorlacius-Ussing, O 2018, Cell-free DNA promoter hypermethylation in plasma as biomarkers for pancreatic adenocarcinoma . in Danske Kræftforskningsdage : Abstract Book ., #90, pp. 98, Danske Kræftforskningsdage 2018, Odense, Denmark, 30/08/2018 .
Aalborg University
Aalborg University
BACKGROUND AND PURPOSE: Defining margins around the Gross Tumour Volume (GTV) to create a Clinical Target Volume (CTV) for head and neck cancer radiotherapy has traditionally been based on presumed knowledge of anatomical routes of spread. However, u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a07b0760d73f99d6b851f2f6b228df10
https://vbn.aau.dk/da/publications/3ed857b8-2d15-4c95-8814-6220c13d3ccd
https://vbn.aau.dk/da/publications/3ed857b8-2d15-4c95-8814-6220c13d3ccd
Publikováno v:
Henriksen, S D, Madsen, P H, Krarup, H & Thorlacius-Ussing, O 2015, ' DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer : A Literature Review ', Pancreas, vol. 44, no. 7, pp. 1036-1045 . https://doi.org/10.1097/MPA.0000000000000487
OBJECTIVES: The aim is to review genes aberrantly methylated in pancreatic cancer. This review focuses on DNA promoter hypermethylation in plasma and serum to describe the most promising genes that may be useful as minimally invasive diagnostic blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde178616186764f90a058175055247c
https://doi.org/10.1097/mpa.0000000000000487
https://doi.org/10.1097/mpa.0000000000000487